Market Will Be Unchanged by 48% Effectiveness of Flu Vaccine This Year

Market Will Be Unchanged by 48% Effectiveness of Flu Vaccine This Year

The CDC recently said this year's flu vaccine was 48% effective. Despite that being lower than half, that's a good number. And for the most part, good or bad effectiveness doesn't change the vaccine market. In this article, we indicate why.


Five Things to Know About the Vaccine Industry in 2016

Five Things to Know About the Vaccine Industry in 2016

A lot happened in vaccines this year, but five trends stay out. The vaccine market continued its growth and innovation in 2016. Merck, Sanofi Pasteur, Pfizer, Glaxo Smith Kline and CSL are among the top companies in the market. Segment growth, the growing obesity challenge and delivery systems were among the trends noted this year. The healthcare market research publisher has studied vaccine markets for a decade, and this year published its report Vaccines 2016.

  • by bcarlson@marketresearch.com
  • February 20 2014
  • flu vaccine


Stronger Flu Season Boosted Vaccine Revenue

Stronger Flu Season Boosted Vaccine Revenue

An upcoming report will have good news for manufacuters of flu vaccine: The lull the industry has exeprienced since 2011 may be over. Influenza vaccines generated $3.1 billion in revenues, according to research we’ve conducted for our 2014 survey of the vaccine industry. This is up 13.2% from the prior year on a relatively severe current flu season in the U.S., but of course it’s not like the balooning sales of ’09 or ’10. We will make the finding in our Vaccines 2014 report (The report is due o...